We aimed to ascertain the oncological outcome of patients undergoing an amputation for sarcoma in our unit. A retrospective analysis of patients undergoing amputation within a two-year period (2007-2009) was undertaken. Patients were identified from our sarcoma database and cross referenced with OPCS codes and HES data to ensure accuracy. A case note review was then undertaken.Introduction
Method
The National Institute of Clinical Excellence (NICE) published clinical guidelines in 2006 defining urgent referral criteria for soft tissue sarcoma to help improve the diagnostic accuracy and overall outcome. Despite these guidelines inadvertent excisions of soft tissue sarcomas continue to occur with alarming frequency potentially compromising patient outcomes. We reviewed the East Midlands Sarcoma Service experience of treating inadvertent excision of STSs and highlight the patient profile, referral pattern, subsequent management and oncological outcome associated with inadvertent resection.Background
Objective
The aim of this study was to assess the financial implications of managing skeletal metastases in a tertiary hospital and explore its impact on the provision of acute care trauma services. We identified 47 patients, surgically treated for skeletal metastases over one-year period. Data were collected on demographics, primary tumour, the bone involved, surgery performed, the type of prosthesis used, length of surgery, hospital stay and the exact indication for orthopaedic intervention. The cost incurred was calculated from the cost of the prosthesis implanted, the number of theatre-sessions utilised and the number of inpatient hospital days.Aim
Methods
